Vor Biopharma Inc (VOR)
0.79
-0.01
(-0.77%)
USD |
NASDAQ |
Nov 22, 16:00
0.79
0.00 (0.00%)
After-Hours: 20:00
Vor Biopharma Free Cash Flow: -99.89M for Sept. 30, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| September 30, 2024 | -99.89M |
| June 30, 2024 | -104.94M |
| March 31, 2024 | -107.58M |
| December 31, 2023 | -101.36M |
| September 30, 2023 | -95.89M |
| June 30, 2023 | -86.73M |
| March 31, 2023 | -93.05M |
| December 31, 2022 | -93.61M |
| Date | Value |
|---|---|
| September 30, 2022 | -93.69M |
| June 30, 2022 | -92.47M |
| March 31, 2022 | -79.13M |
| December 31, 2021 | -73.04M |
| September 30, 2021 | -69.39M |
| June 30, 2021 | -61.25M |
| March 31, 2021 | -52.64M |
| December 31, 2020 | -40.45M |
Free Cash Flow Range, Past 5 Years
-107.58M
Minimum
Mar 2024
-40.45M
Maximum
Dec 2020
-84.07M
Average
-92.76M
Median
Free Cash Flow Benchmarks
| Organon & Co | 646.00M |
| NovaBay Pharmaceuticals Inc | -4.812M |
| Palatin Technologies Inc | -32.57M |
| iBio Inc | -16.93M |
| Theriva Biologics Inc | -18.84M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -23.28M |
| Cash from Investing (Quarterly) | -0.034M |
| Cash from Financing (Quarterly) | 0.041M |
| Free Cash Flow Per Share (Quarterly) | -0.3406 |
| Free Cash Flow Yield | -185.5% |